BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright ©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Feb 27, 2026; 18(2): 114206
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.114206
Fatigue and circadian rhythm in non-cirrhotic primary biliary cholangitis: An exploratory comparison with primary sclerosing cholangitis and healthy controls
Armando Curto, Michele Tanturli, Rocco Gabriele Iamello, Pietro Rossi, Giulia Mengozzi, Leonardo Dei, Tommaso Mello, Tommaso Innocenti, Gabriele Dragoni, Andrea Galli, Erica Nicola Lynch
Armando Curto, Rocco Gabriele Iamello, Tommaso Innocenti, Gabriele Dragoni, Andrea Galli, Erica Nicola Lynch, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, Gastroenterology Research Unit, University of Florence, Florence 50134, Tuscany, Italy
Michele Tanturli, Pietro Rossi, Giulia Mengozzi, Leonardo Dei, Tommaso Mello, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Florence 50134, Tuscany, Italy
Co-corresponding authors: Andrea Galli and Erica Nicola Lynch.
Author contributions: Curto A and Lynch EN conceived and designed the study, and drafted the manuscript; Tanturli M conducted statistical analyses and critically revised the manuscript for important intellectual content; Rossi P, Mengozzi G, and Dei L contributed with data collection; Iamello RG, Mello T, and Galli A contributed to data interpretation and critically revised the manuscript; Innocenti T and Dragoni G contributed with data collection and critically revised the manuscript; Galli A and Lynch EN contributed equally to this manuscript and are co-corresponding authors; All authors accepted the final version of the manuscript.
Institutional review board statement: The study protocol conforms to the ethical guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of Azienda Comitato Etico Regione Toscana.
Informed consent statement: Written informed consent was obtained from all participants prior to enrolment.
Conflict-of-interest statement: Lynch EN reports speaker fees for Ipsen and Gilead and travel grants form MSD, Gilead and Orphalan. Innocenti T reports speaker fees from Aurora Biofarma and Ferring, and travel grants from Abbvie, Alfasigma, Celltrion, Eli Lilly, Ferring, Malesci and Pfizer. Dragoni G reports speaker fees from Alfasigma, Ferring, Johnson & Johnson, Lionhealth, Novartis, Pfizer, and Takeda, and has served in advisory board for AbbVie, Celltrion Healthcare, Eli Lilly, Johnson and Johnson and Pfizer. The other authors declare no conflict of interest.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: Aggregate results are reported in the article (with additional details in the Supplemental material cited in the methods). De-identified individual-level data (questionnaire scores and selected clinical variables) can be shared upon reasonable request to the corresponding author, contingent on approval by the Regional Ethics Committee of Tuscany - Area Vasta Centro and a General Data Protection Regulation-compliant data-use agreement; raw identifiers and full medical records will not be shared. The dataset includes instruments listed in the protocol (FIS, ESS, MEQ- and extracted clinical variables.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Erica Nicola Lynch, MD, Consultant, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, Gastroenterology Research Unit, University of Florence, Largo Brambilla 3, Florence 50134, Tuscany, Italy. ericanicola.lynch@unifi.it
Received: September 15, 2025
Revised: October 5, 2025
Accepted: December 12, 2025
Published online: February 27, 2026
Processing time: 152 Days and 3.1 Hours
Abstract
BACKGROUND

Fatigue is common and debilitating in primary biliary cholangitis (PBC) without clear relation to disease stage; mechanisms remain unclear. Circadian disruption is reported in end-stage liver disease, but evidence in non-cirrhotic PBC, and links to fatigue, is scarce.

AIM

To investigate the severity and phenotype of fatigue, daytime sleepiness, and chronotype in non-cirrhotic PBC, and compare findings with matched healthy controls (HC) and non-cirrhotic primary sclerosing cholangitis (PSC).

METHODS

Participants completed the Fatigue Impact Scale, Epworth Sleepiness Scale, and Morningness-Eveningness Questionnaire Self-Assessment. Demographics, sleep habits, employment, and fatigue subtype (mental vs muscular) were recorded. In PBC/PSC, PBC-40 fatigue/itch domains and disease characteristics were analyzed. Group comparisons and multivariable models evaluated associations of fatigue phenotype and chronotype with demographic/disease variables.

RESULTS

We enrolled 152 individuals: 61 PBC, 30 PSC, and 61 HC. Global fatigue scores did not differ across groups. Muscular fatigue predominated in PBC/PSC, whereas HC more often reported mental fatigue; this pattern persisted after stratifying by employment and sex. In adjusted analyses, HC had lower odds of muscular fatigue than PBC [odd ratio (OR) = 0.30, 95% confidence interval (CI): 0.14-0.63; P = 0.002]; PSC did not differ from PBC (OR = 1.25, 95%CI: 0.44-3.71; P = 0.681). Older age independently increased the odds of muscular fatigue (OR = 1.04 per year, 95%CI: 1.01-1.07; P = 0.016). Daytime sleepiness was low and similar between groups. Morningness-Eveningness Questionnaire Self-Assessment scores clustered in the intermediate range; age, not disease, predicted greater morningness.

CONCLUSION

In non-cirrhotic PBC, fatigue shows a predominantly muscular phenotype independent of demographics/occupation and decoupled from conventional disease metrics. Chronotype and daytime alertness appear largely preserved, with age driving modest morningness. Findings support integrating fatigue phenotyping into assessment, prioritizing muscle-targeted interventions, and using carefully selected controls and objective endpoints in future studies.

Keywords: Chronotype; Daytime sleepiness; Cholestatic disorders; Mental; Muscular; Primary biliary cholangitis; Primary sclerosing cholangitis

Core Tip: In non-cirrhotic primary biliary cholangitis, fatigue burden is similar to healthy controls and primary sclerosing cholangitis, but its phenotype is predominantly muscular (approximately 69%), independent of sex, age-adjusted employment, or routine disease metrics; daytime sleepiness and sleep duration are low/normal, and chronotype clusters in the intermediate range, with age - not disease - driving greater morningness. Primary sclerosing cholangitis shows a similar (weaker) direction of effect. These findings support routine fatigue phenotyping and muscle-focused interventions over cholestasis-directed therapies, and argue for objective endpoints (e.g., 31phosphorus magnetic resonance spectroscopy, actigraphy) in future trials.